Market revenue in 2023 | USD 24.3 million |
Market revenue in 2030 | USD 30.5 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.81% in 2023. Horizon Databook has segmented the Middle East & Africa clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East and North Africa (MENA) remains an extremely under-represented region for clinical trials. Most of the Middle East is part of the advanced world and the remaining region is mainly a part of newly developed economies with established medical infrastructure identical to Eastern Europe.
MEA consists of large Europid population with diseases similar to those in the West, including respiratory diseases, cancer, and cardiovascular diseases.
Increasing demand for medication, growing population, rising incidence of lifestyle-associated diseases & rare diseases in MEA are providing opportunities for conducting clinical trials in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account